Titan Pharmaceuticals Announces Termination of Equity Financing Agreement with Cornell Capital Partners

March 14, 2007 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Titan Pharmaceuticals, Inc. (AMEX: TTP) today announced that it has terminated the equity line of credit agreement with Cornell Capital Partners, LP that it entered into in September 2005.

Twitter
LinkedIn
Facebook
Email
Print

Alliances